@article {De-Leon2021.08.10.21261856, author = {Hilla De-Leon and Francesco Pederiva}, title = {Using a physical model and aggregate data from Israel to estimate the current (July 2021) efficacy of the Pfizer-BioNTech vaccine}, elocation-id = {2021.08.10.21261856}, year = {2021}, doi = {10.1101/2021.08.10.21261856}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {From the end of June 2021, the state of Israel, where 60\% of the population is vaccinated with an mRNA BNT162b2 vaccine, has an increase in the daily morbidity. This increase may be a result of different events: a temporal decline of the vaccine{\textquoteright}s efficacy; Lower efficacy of the vaccine against the current Delta ((B.1.617.2) variant (which is now the dominant strain in Israel); A result of lack of social restrictions, a highly contagious variant, or any combination of the above. We found, by using a novel spatial-dynamic model and recent aggregate data from Israel, that this new surge of cases is partiality due to a decline in the shielding of those who were vaccinated about six months ago. Also, we found a decrease in the vaccine{\textquoteright}s efficacy against severe morbidity for the early elderly population compared to the rest of the vaccinated population. These results, which are consistent with recent studies, emphasize the high ability of the model in evaluating the time- and age- dependent efficacy of the vaccine for different age groups and enables to predict the spread of the pandemic as a function of such efficacy.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialAll the data used for this paper is open to the public and available onlineFunding StatementThere is no funding for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the data was taken from: https://github.com/dancarmoz/israel_moh_covid_dashboard_data https://data.gov.il/dataset/covid-19All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data was taken from: https://github.com/dancarmoz/israel_moh_covid_dashboard_data https://data.gov.il/dataset/covid-19 https://github.com/dancarmoz/israel_moh_covid_dashboard_data https://data.gov.il/dataset/covid-19}, URL = {https://www.medrxiv.org/content/early/2021/08/11/2021.08.10.21261856}, eprint = {https://www.medrxiv.org/content/early/2021/08/11/2021.08.10.21261856.full.pdf}, journal = {medRxiv} }